Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about McKesson
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
McKesson completed the acquisition of an 80% controlling interest in PRISM Vision Holdings, a leading ophthalmology and retina management services provider, for approximately $850 million, to expand its retinal and ophthalmology platform and enhance clinical services and distribution offerings[2].
McKesson reported strong fiscal 2025 third-quarter results, with an 18% increase in consolidated revenues to $95.3 billion, driven by growth in the U.S. Pharmaceutical segment. Adjusted Earnings per Diluted Share rose to $8.03, and the company raised its fiscal 2025 Adjusted Earnings guidance to $32.55 to $32.95[1].
McKesson launched the Precision Care Companion (PCC), a precision oncology initiative to guide practices in biomarker-driven cancer care, providing education, technology enhancements, and operational support to improve treatment outcomes and reduce delays[4].
Open job positions at McKesson
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

